Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
6.08
-0.23 (-3.65%)
Sep 20, 2024, 3:34 PM EDT - Market open
Mind Medicine (MindMed) Employees
Mind Medicine (MindMed) had 57 employees as of December 31, 2023. The number of employees increased by 9 or 18.75% compared to the previous year.
Employees
57
Change (1Y)
9
Growth (1Y)
18.75%
Revenue / Employee
n/a
Profits / Employee
-$1,790,193
Market Cap
493.88M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 57 | 9 | 18.75% |
| Dec 31, 2022 | 48 | 7 | 17.07% |
| Dec 31, 2021 | 41 | 19 | 86.36% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cross Country Healthcare | 13,131 |
| Sharecare | 3,352 |
| National Research | 435 |
| COMPASS Pathways | 186 |
| Entrada Therapeutics | 159 |
| Absci | 155 |
| Acelyrin | 135 |
| EyePoint Pharmaceuticals | 121 |
MNMD News
- 10 days ago - MindMed Announces New Employee Inducement Grants - Business Wire
- 16 days ago - MindMed to Participate in September Investor Conferences - Business Wire
- 5 weeks ago - Psychedelic Stocks: Focus On Their Cash - Seeking Alpha
- 5 weeks ago - Mind Medicine (MindMed) Inc. (MNMD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - MindMed readying Phase III trials for LSD therapy to treat anxiety - Market Watch
- 5 weeks ago - Pacific Defense Announces US Army CMFF Program Team - Business Wire
- 5 weeks ago - MindMed Reports Second Quarter 2024 Financial Results and Business Updates - Business Wire
- 5 weeks ago - FDA Rejection of MDMA Therapy Isn't End of Psychedelic-Drug Candidates - Barrons